These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. Kane JM; Leucht S; Carpenter D; Docherty JP; J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142 [TBL] [Abstract][Full Text] [Related]
5. [Pharmaco-therapeutic evaluation of medical treatments of adult autistics and multi-handicapped patients in a public mental health unit]. Armand-Branger S; Poisson N; Gaudoneix-Taïeb M; Ramos O Encephale; 2009 Sep; 35(4):370-6. PubMed ID: 19748374 [TBL] [Abstract][Full Text] [Related]
6. Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey. Diatta T; Blazejewski S; Portier A; Lignot S; Quesnot A; Moore N; Fourrier-Réglat A Fundam Clin Pharmacol; 2007 Aug; 21(4):371-8. PubMed ID: 17635175 [TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810 [TBL] [Abstract][Full Text] [Related]
8. Antipsychotic medication utilization trends among Texas veterans: 1997-2002. Yang M; Barner JC; Lawson KA; Rascati KL; Wilson JP; Crismon ML; Worchel J; Mascarenas CA Ann Pharmacother; 2008 Sep; 42(9):1229-38. PubMed ID: 18682544 [TBL] [Abstract][Full Text] [Related]
9. Practice regarding antipsychotic therapy: a cross-sectional survey in two Norwegian hospitals. Johnsen E; Svingen GF; Jørgensen HA Nord J Psychiatry; 2004; 58(4):313-7. PubMed ID: 15370781 [TBL] [Abstract][Full Text] [Related]
10. The association between class of antipsychotic and rates of hospitalization: results of a retrospective analysis of data from the 2005 Medicare current beneficiary survey. Kennedy J; Tien YY; Cohen LJ; Sclar DA; Liu D; Blodgett EG; Engle J Clin Ther; 2009 Dec; 31(12):2931-9. PubMed ID: 20110033 [TBL] [Abstract][Full Text] [Related]
11. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing]. Mercier C; Bret P; Bret MC; Queuille E Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368 [TBL] [Abstract][Full Text] [Related]
12. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness]. Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM; Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients. Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436 [TBL] [Abstract][Full Text] [Related]
14. Patterns of clinical use of antipsychotics in hospitalized psychiatric patients. Mauri MC; Regispani F; Beraldo S; Volonteri LS; Ferrari VM; Fiorentini A; Invernizzi G Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):957-63. PubMed ID: 16051409 [TBL] [Abstract][Full Text] [Related]
15. Prescribing for inpatients with schizophrenia: an international multi-center comparative study. Bitter I; Chou JC; Ungvari GS; Tang WK; Xiang Z; Iwanami A; Gaszner P Pharmacopsychiatry; 2003 Jul; 36(4):143-9. PubMed ID: 12905100 [TBL] [Abstract][Full Text] [Related]
16. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice. Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons. Fraguas D; Correll CU; Merchán-Naranjo J; Rapado-Castro M; Parellada M; Moreno C; Arango C Eur Neuropsychopharmacol; 2011 Aug; 21(8):621-45. PubMed ID: 20702068 [TBL] [Abstract][Full Text] [Related]
18. [Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia]. Brunot A; Lachaux B; Sontag H; Casadebaig F; Philippe A; Rouillon F; Cléry-Melin P; Hergueta T; Llorca PM; Moreaudefarges T; Guillon P; Lebrun T Encephale; 2002; 28(2):129-38. PubMed ID: 11972139 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004. Wolfsperger M; Greil W; Rössler W; Grohmann R J Affect Disord; 2007 Apr; 99(1-3):9-17. PubMed ID: 16989907 [TBL] [Abstract][Full Text] [Related]